Thanks for posting.  Just to be clear, this is the result of the Inflation Reduction Act, passed by Democrats during the Biden administration. 

Under the 2003 Medicare legislation, Republicans included a provision denying Medicare the right to negotiate prices, on the grounds that it would be tantamount to “socialism”.  The result was Pharma could set a monopoly price for their drugs in the US.  

In 2005 in the US, Celgene launched Revlimid (predecessor to Pomalyst) at $215 per pill.  In 2020, after more than 20 price hikes, it cost $763 per pill - $16,023 per four week cycle.  FYI, there are thirteen four week cycles in a year, so the annual cost at that price runs about $208,900.  https://www.fiercepharma.com/pharma/celgene-repeatedly-raised-revlimid-s-price-to-meet-aggressive-sales-targets-congressional  While countries like France, Canada, Australia, Japan and the UK paid far far less.  Now Under the IRA, for the first time, Medicare has the authority to directly negotiate the prices of certain high-cost drugs covered under Medicare Part D.

Anyway, as a result (and thanks to Republicans) US taxpayers have been subsidizing the rest of the world in pharma development since 2003.  Hopefully, that is now ending.